Holen Sie sich die Stockscreener-App
3.67
4.56%
0.16
Schlusskurs vom Vortag:
$3.51
Offen:
$3.51
24-Stunden-Volumen:
36,319
Relative Volume:
0.17
Marktkapitalisierung:
$99.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-49.81M
KGV:
-1.7022
EPS:
-2.156
Netto-Cashflow:
$-42.93M
1W Leistung:
-0.27%
1M Leistung:
+19.54%
6M Leistung:
+8.58%
1J Leistung:
-71.15%
1-Tages-Spanne:
$3.47
$3.70
1-Wochen-Bereich:
$3.41
$3.92
52-Wochen-Spanne:
$1.60
$15.04
Alto Neuroscience Inc Stock (ANRO) Company Profile
Firmenname
Alto Neuroscience Inc
Sektor
Branche
Telefon
773-255-5012
Adresse
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Vergleichen Sie ANRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
3.67 | 95.04M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-23 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-09-03 | Eingeleitet | Wedbush | Outperform |
| 2024-02-27 | Eingeleitet | Jefferies | Buy |
| 2024-02-27 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-27 | Eingeleitet | Stifel | Buy |
| 2024-02-27 | Eingeleitet | TD Cowen | Outperform |
| 2024-02-27 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Alto Neuroscience Inc Aktie (ANRO) Neueste Nachrichten
What’s next for Alto Neuroscience Inc. stock priceWeekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Chart overlay techniques for tracking Alto Neuroscience Inc.Weekly Investment Recap & Weekly High Conviction Ideas - Newser
Historical volatility pattern of Alto Neuroscience Inc. visualizedWeekly Risk Report & AI Powered Trade Plan Recommendations - Newser
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers – ANRO - FinancialContent
Securities Litigation Risks and Investor Implications in Biotech: Focusing on Alto Neuroscience - AInvest
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - MarketScreener
Is Alto Neuroscience Inc. being accumulated by smart money2025 Pullback Review & Community Consensus Trade Signals - خودرو بانک
Can Alto Neuroscience Inc. expand into new marketsTrade Exit Report & Free Expert Verified Stock Movement Alerts - خودرو بانک
What are analysts’ price targets for Alto Neuroscience Inc.2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - خودرو بانک
Nuveen LLC Takes $302,000 Position in Alto Neuroscience, Inc. $ANRO - Defense World
Does Alto Neuroscience Inc. have pricing power2025 Trading Recap & Reliable Price Breakout Signals - خودرو بانک
Alto Neuroscience, Inc. Investors: Please contact the - GlobeNewswire
Levi & Korsinsky Notifies Alto Neuroscience, Inc. (ANRO) InvestorsLead Plaintiff Deadline on September 19, 2025 - ACCESS Newswire
Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 19, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
Will Alto Neuroscience Inc. outperform tech stocksJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Regression analysis insights on Alto Neuroscience Inc. performanceJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - Newser
Does Alto Neuroscience Inc. stock reflect fundamentalsJuly 2025 Highlights & Weekly High Return Opportunities - خودرو بانک
ANRO DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Alto Neuroscience, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 19 Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Lawsuit Filed Against Alto Neuroscience, Inc. (ANRO)Recover LossesContact Levi & Korsinsky Before September 19, 2025 - ACCESS Newswire
Alto Neuroscience, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your RightsANRO - WV News
Lost Money on Alto Neuroscience, Inc. (ANRO)? Join Class - GlobeNewswire
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Your Wyoming Link
Using Python tools to backtest Alto Neuroscience Inc. strategiesEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - Newser
Published on: 2025-09-04 06:28:13 - خودرو بانک
Technical signs of recovery in Alto Neuroscience Inc.Breakout Watch & Weekly High Return Stock Forecasts - Newser
What are Alto Neuroscience Inc.’s recent SEC filings showingMarket Performance Recap & Long-Term Safe Investment Plans - خودرو بانک
PDE4B Inhibitor Market Poised for Strong Growth by 2034 | DelveInsight - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - Morningstar
Published on: 2025-09-03 09:03:31 - Newser
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain OfficersANRO - PR Newswire
Shareholders That Lost Money on Alto Neuroscience, Inc. (ANRO) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - The Globe and Mail
ALTO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ANRO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Backtesting results for Alto Neuroscience Inc. trading strategies2025 Retail Activity & AI Driven Price Forecasts - Newser
Should I buy Alto Neuroscience Inc. stock nowMarket Volume Report & Capital Protection Trade Alerts - خودرو بانک
Is Alto Neuroscience Inc.’s growth already priced inJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - khodrobank.com
What machine learning models say about Alto Neuroscience Inc.2025 Big Picture & Real-Time Stock Entry Alerts - Newser
ANRO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ANRO STOCK NEWS: Alto Neuroscience, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action - PR Newswire
Shareholders of Alto Neuroscience, Inc. (ANRO): Protect Your Rights Before September 19, 2025Contact Levi & Korsinsky - The Globe and Mail
Bearish Setup: Should I buy Alto Neuroscience Inc. stock nowEarnings Miss & Reliable Price Breakout Signals - خودرو بانک
Investors SueWallSt Over Alto Neuroscience, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Earnings visualization tools for Alto Neuroscience Inc.Earnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Alto Neuroscience Inc. stock daily chart insightsMarket Activity Recap & Proven Capital Preservation Tips - Newser
Is Alto Neuroscience Inc. forming a bullish divergence2025 Analyst Calls & Advanced Technical Signal Analysis - خودرو بانک
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of September 19, 2025 Lead Plaintiff Deadline in the Alto Neuroscience, Inc. (ANRO) Class Action – Investors With Significant Losses Encouraged to Contact the Firm - GlobeNewswire
Alto Neuroscience Class Action Lawsuit Filed Against Officers. - AInvest
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) SHAREHOLDER ALERT: - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Alto Neuroscience, Inc.(ANRO) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Will Alto Neuroscience Inc. face regulatory challenges2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - خودرو بانک
Levi & Korsinsky Urges Alto Neuroscience, Inc. (ANRO) Shareholders to Act Before Lead Plaintiff Deadline September 19, 2025 - ACCESS Newswire
Finanzdaten der Alto Neuroscience Inc-Aktie (ANRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):